{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:25:55Z","timestamp":1751052355116},"reference-count":23,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":8163,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1990,11]]},"abstract":"<jats:p>The blood pressure response to a new sustained\u2010release formulation of nifedipine was evaluated in an 8\u2010week, double\u2010blind, placebo\u2010controlled study. Twenty\u2010nine patients with mild essential hypertension were randomized to receive placebo (N = 9), 30 mg nifedipine (N = 10), or 60 mg nifedipine (N = 10). During treatment, 30\u2010mg and 60\u2010mg doses of nifedipine administered once daily decreased office blood pressures from 137\/98 \u00b1 8\/2 mm Hg and 141\/98 \u00b1 15\/2 mm Hg at baseline, respectively, to 126\/89 \u00b1 9\/7 mm Hg and 126\/86 \u00b1 6\/7 mm Hg (<jats:italic>P<\/jats:italic> &lt; .005). Noninvasive automatic ambulatory blood pressure monitoring demonstrated a marginally significant (<jats:italic>P<\/jats:italic> &lt; .10) reduction in the mean 24\u2010hour blood pressure of 2\/6 \u00b1 8\/8 mm Hg and 5\/6 \u00b1 9\/9 mm Hg for patients taking 30 mg and 60 mg nifedipine once daily, respectively. Diastolic blood pressure load (the percentage of ambulatory diastolic blood pressure readings greater than 90 mm Hg) during 24 hours was decreased by 41% and 35%, with 30 mg and 60 mg nifedipine administered once daily, respectively. No significant dose response to nifedipine at these dose levels was observed. Although the once\u2010daily formulation of nifedipine achieved effective control of office blood pressure, similar control was not observed in awake and 24\u2010hour periods in all patients.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1990.tb03588.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T21:42:18Z","timestamp":1362778938000},"page":"1012-1019","source":"Crossref","is-referenced-by-count":9,"title":["Antihypertensive Effects of a New Sustained\u2010Release Formulation of Nifedipine"],"prefix":"10.1002","volume":"30","author":[{"given":"Prince K.","family":"Zachariah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary L.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon G.","family":"Sheps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Schirger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher A.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew G.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.17.479"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1977225part1528"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0773.1981.tb03365.x","article-title":"Calcium blockade as a therapeutic principle in arterial hypertension","volume":"49","author":"Pedersen Lederballe O","year":"1981","journal-title":"Acta Pharmacol Toxicol"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(83)90977-7"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198530030-00002"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/1.suppl_2.15"},{"issue":"2","key":"e_1_2_1_8_2","first-page":"95","article-title":"Nifedipine tablets for hypertension: A study using continuous ambulatory intra\u2010arterial recording","volume":"59","author":"Hornung RS","year":"1983","journal-title":"Postgrad Med J"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198501000-00003"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1986.8"},{"key":"e_1_2_1_11_2","first-page":"740","article-title":"Evaluation of the Del Mar Avionics automatic ambulatory blood pressure\u2010recording device","volume":"56","author":"Sheps SG","year":"1981","journal-title":"Mayo Clin Proc"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198904000-00001"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1982.tb02021.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198311000-00025"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(82)90327-8"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.7.2.171"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-6196(12)65503-7"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/1.3.274S"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1001\/archinte.1989.00390090077016","article-title":"Assessing duration of antihypertensive effects with whole\u2010day blood pressure monitoring","volume":"149","author":"Cheung DG","year":"1989","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.135"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90499-1"},{"key":"e_1_2_1_22_2","first-page":"37","article-title":"Slow\u2010release nifedipine: Effect on the circadian rhythm of blood pressure in essential hypertension","volume":"42","author":"Portaluppi F","year":"1987","journal-title":"Acta Cardiol (Brux)"},{"issue":"4","key":"e_1_2_1_23_2","first-page":"391S","article-title":"Blood pressure circadian rhythm in essential hypertension","volume":"55","author":"Craig Millar MW","year":"1978","journal-title":"Clin Sci Mol Med"},{"key":"e_1_2_1_24_2","doi-asserted-by":"crossref","first-page":"II42","DOI":"10.1161\/01.HYP.11.3_Pt_2.II42","article-title":"Side effects of calcium channel blockers","volume":"11","author":"Russell RP","year":"1988","journal-title":"Hypertension"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1990.tb03588.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1990.tb03588.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T07:26:09Z","timestamp":1697959569000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1990.tb03588.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["10.1002\/j.1552-4604.1990.tb03588.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1990.tb03588.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,11]]}}}